PAPER Lemaire P, Leclère M
SEARCH RESULTS
329940 RESULTS
PAPER Mastwyk M, Ames D, Ellis KA, Chiu E, Dow B
Disclosing a dementia diagnosis: what do patients and family consider important?
Int Psychogeriatr. 2014 Aug;26(8):1263-72. Epub 2014 May 1 PubMed: 24784005PAPER Khairallah MI, Kassem LA, Yassin NA, El Din MA, Zekri M, Attia M
The hematopoietic growth factor "erythropoietin" enhances the therapeutic effect of mesenchymal stem cells in Alzheimer's disease.
Pak J Biol Sci. 2014 Jan 1;17(1):9-21. PubMed: 24783773PAPER Decourt B, Mobley W, Reiman E, Shah RJ, Sabbagh MN
Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down Syndrome.
J Alzheimers Dis Parkinsonism. 2013 Mar 20;Suppl 7:002. PubMed: 24782952PAPER
New method predicts individualized progression of Alzheimer's disease.
J Gerontol Nurs. 2014 Jan;40(1):5. PubMed: 24783228PAPER Bhattacharjee S, Zhao Y, Hill JM, Percy ME, Lukiw WJ
Aluminum and its potential contribution to Alzheimer's disease (AD).
Front Aging Neurosci. 2014;6:62. Epub 2014 Apr 8 PubMed: 24782759PAPER Stewart-Archer LA, Afghani A, Toye CM, Gomez FA
Dialogue on Ideal End-of-Life Care for Those With Dementia.
Am J Hosp Palliat Care. 2014 Apr 29; PubMed: 24782574PAPER Vanni N, Fruscione F, Ferlazzo E, Striano P, Robbiano A, Traverso M, Sander T, Falace A, Gazzerro E, Bramanti P, Bielawski J, Fassio A, Minetti C, Genton P, Zara F
Impairment of Ceramide Synthesis Causes a Novel Progressive Myoclonus Epilepsy.
Ann Neurol. 2014 Apr 30; PubMed: 24782409PAPER Iravani MM, Sadeghian M, Rose S, Jenner P
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
J Neural Transm. 2014 Apr 30; PubMed: 24781752PAPER Knight EM, Gandy S
Immunomodulation and AD--down but not out.
J Clin Immunol. 2014 Jul;34 Suppl 1:S70-3. Epub 2014 Apr 30 PubMed: 24781637PAPER Harrison C
Neurodegenerative disorders: Blood-based biomarkers for Alzheimer's disease?
Nat Rev Drug Discov. 2014 Apr 30;13(5) PubMed: 24781547PAPER Gromova OA, Torshin II, Gogoleva IV
[Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia.]
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(3 vypusk 2 Insul't):43-50. PubMed: 24781241PAPER Osman EY, Miller MR, Robbins KL, Lombardi AM, Atkinson AK, Brehm AJ, Lorson CL
Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models.
Hum Mol Genet. 2014 Apr 29; PubMed: 24781211Dementia Screening and Detection Meeting
CONFERENCE 2011-11-22 00:00:00-2011-11-22 00:00:00 New York, New York, U.S.A. 22 November 2011 0
Neurodegenerative Disorders-Immunotherapy and Biomarkers
CONFERENCE 2009-05-28 00:00:00-2009-05-29 00:00:00 Rudbeck Laboratory, Uppsala, Sweden 28 May 2009 to 29 May 2009 Immunotherapy targeting abnormal protein aggregates has emerged as one of the most promising treatment strategies for neurodegenerative disorders. In a pioneer study, immunization against amyl
Current Filters
No filters selected